JP Morgan Chase
ONC

JP Morgan Chase’s BeOne Medicines Ltd ONC Stock Holding History

JP Morgan Chase’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,600
Closed -$7.41M – 7808
2025
Q2 		$7.41M Sell
30,600
-12,000
-28% -$2.94M ﹤0.01% 2803
2025
Q1 		$11.6M Buy
42,600
+30,600
+255% +$7.15M ﹤0.01% 2411
2024
Q4 		$2.22M Buy
+12,000
New +$2.45M ﹤0.01% 4076
2020
Q3 		– Sell
-30,000
Closed -$5.65M – 5843
2020
Q2 		$5.65M Buy
+30,000
New +$4.88M ﹤0.01% 2367
2019
Q1 		– Sell
-30,000
Closed -$4.21M – 6098
2018
Q4 		$4.21M Buy
+30,000
New +$3.98M ﹤0.01% 2717
2018
Q3 		– Sell
-18,000
Closed -$2.77M – 5863
2018
Q2 		$2.77M Buy
+18,000
New +$3.21M ﹤0.01% 3151

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase's ONC Position: Q1 2026 in Review

JP Morgan Chase increased its BeOne Medicines Ltd (ONC) stake by 941% in Q1 2026, buying an estimated $22.7M and bringing the position to 77,538 shares worth $22M. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

JP Morgan Chase first reported a position in ONC in Q2 2016 and has held it in 35 quarters since. The position peaked at $77.9M in Q2 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • JP Morgan Chase held 77,538 shares of BeOne Medicines Ltd worth $22M as of Q1 2026.
  • JP Morgan Chase bought 70,093 BeOne Medicines Ltd shares in Q1 2026, an estimated $22.7M.
  • BeOne Medicines Ltd made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1990 holding.
  • JP Morgan Chase first reported a position in BeOne Medicines Ltd in Q2 2016 and has held it in 35 quarters since.
  • JP Morgan Chase's BeOne Medicines Ltd position peaked at $77.9M in Q2 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.